kidney disease
Renalytix to Raise $20.3M in Private Placement
The firm intends to allocate money from the sale toward clinical product development, sales and marketing, and corporate support and financing costs.
Jana Care, Roche Collaborate to Develop POC Blood Tests for Kidney, Heart Disease
Jana Care's digitally connected platform allows for at-home testing with fingerstick blood samples.
Renalytix, Partners Launch $10M Consortium to Develop Kidney Disease Drug Response Tests
Renalytix said it will receive about $1 million in consortium funding to oversee commercial translation activities around the tests.
Numares Health Gets €40M Financing from European Investment Bank, Existing Investors
Numares will use €20 million from the EIB for research and development and the complementary €20 million from other investors to commercialize its technology.
The firm's test runs on traditional clinical chemistry analyzers and measures the levels of a protein indicating acute kidney injury.
Oct 31, 2022
Renalytix Posts $2.9M in Revenue for Fiscal 2022
Jun 30, 2022
Renalytix Fiscal Q3 Revenues Up 31 Percent
Jun 24, 2022
Almac, AstraZeneca Strike CDx Development Pact
Oct 21, 2021
Renalytix Posts $1.5M in Revenues for Fiscal 2021
Apr 14, 2021
Calciscon Raises $2.7M in Series A Round
Mar 19, 2021
Mar 17, 2021
Mar 16, 2021
NephroSant Raises $16M in Series A Funding Round
Mar 2, 2021